Director/PDMR Shareholding

RNS Number : 2603E

Epistem Holdings plc

07 April 2014

 



Epistem Holdings Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13^th July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, executive Directors, Matthew Walls, Dr Catherine Booth and John Rylands, each increased their beneficial interests in the Company by 345 ordinary shares of 1.5p each. These shares were acquired on 28^th January 2014, 28^th February 2014 and 28^th March 2014 at prices of 323p, 328p and 328p respectively. Executive Director, Allan Brown, joined the plan on 1^st February 2014 and has acquired a beneficial interest in the Company of 228 ordinary shares of 1.5p each. These shares were acquired on 28^th February 2014 and 28^th March 2014 at prices of 328p and 328p respectively.

Following these transactions, the current beneficial interests of the executive Directors are set out below:

                                                Ordinary Shares                       %

Matthew Walls                           11,287                                    0.12%

Dr Catherine Booth                  985,642                                  10.11%

John Rylands                            195,540                                    2.01%

Allan Brown                                    228                                   0.002%

Epistem further announces that it was informed on 4^th April 2014 that, on that day, Dr Catherine Booth transferred 4,877 ordinary shares of 1.5 pence each to her Self Invested Personal Pension fund at a price of 328p Following this transaction, Dr. Catherine Booth's beneficial interest remains unchanged at 985,642 ordinary shares representing 10.11% of the Company's issued share capital.

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

John Rylands, Finance Director                                                 [phone]

Peel Hunt LLP

James Steel /Clare Terlouw                                                       [phone]

 

END

 

 

RDSBUGDSXSGBGSR